INTERPHEX Launches Online Resource for Pharma, Bio, and Device Content
The platform provides access to case studies, new technologies, expert insight, published and peer-reviewed articles, webinars, news updates, videos, and interviews.
INTERPHEX announced on April 23, 2020 that it is launching RECONNEX 365, a year-round online resource for pharma, bio, and device development and manufacturing content and information.
The platform provides access to case studies, new technologies, expert insight, published and peer-reviewed articles, webinars, news updates, videos, and interviews, according to a company press release. Exhibitors at INTERPHEX on April 20–22, 2021 at the Javits Center in New York, NY will have the ability to digitally introduce new and existing technical content, technologies, and solutions, while attendees will be able to schedule onsite meetings to experience the products, technologies, and services.
"Our new online resource reimagines procurement strategies and enables one to stay connected to the industry and leading suppliers year-round, setting companies with procurement needs up for future success," said Kate Scott, event director, INTERPHEX, in the press release. "Leading suppliers continue to select INTERPHEX to feature their innovative technologies, products, and services designed to reduce cost, increase productivity, and maximize efficiency."
Source: INTERPHEX
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
